Korean J Intern Med.
2014 Jan;29(1):23-26. 10.3904/kjim.2014.29.1.23.
Risks associated with sunitinib use and monitoring to improve patient outcomes
- Affiliations
-
- 1Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. sooncb@catholic.ac.kr
- KMID: 1792008
- DOI: http://doi.org/10.3904/kjim.2014.29.1.23
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
- A Case of Sunitinib-Induced Destructive Thyroiditis
- A case of thyrotoxicosis after sunitinib treatment
- Hypoglycemic Coma in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
- Sunitinib-induced hypothyroidism
